488 related articles for article (PubMed ID: 10342083)
1. Long-term depot-medroxyprogesterone acetate and bone mineral density.
Tang OS; Tang G; Yip P; Li B; Fan S
Contraception; 1999 Jan; 59(1):25-9. PubMed ID: 10342083
[TBL] [Abstract][Full Text] [Related]
2. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
Paiva LC; Pinto-Neto AM; Faundes A
Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
[TBL] [Abstract][Full Text] [Related]
4. Bone density in long term users of depot medroxyprogesterone acetate.
Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
[TBL] [Abstract][Full Text] [Related]
5. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
[TBL] [Abstract][Full Text] [Related]
6. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
Orr-Walker BJ; Evans MC; Ames RW; Clearwater JM; Cundy T; Reid IR
Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
[TBL] [Abstract][Full Text] [Related]
7. Forearm bone density in users of Depo-Provera as a contraceptive method.
Bahamondes L; Perrotti M; Castro S; Faúndes D; Petta C; Bedone A
Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
[TBL] [Abstract][Full Text] [Related]
8. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
Virutamasen P; Wangsuphachart S; Reinprayoon D; Kriengsinyot R; Leepipatpaiboon S; Gua C
Asia Oceania J Obstet Gynaecol; 1994 Sep; 20(3):269-74. PubMed ID: 7811192
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
Wanichsetakul P; Kamudhamas A; Watanaruangkovit P; Siripakarn Y; Visutakul P
Contraception; 2002 Jun; 65(6):407-10. PubMed ID: 12127638
[TBL] [Abstract][Full Text] [Related]
10. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
[TBL] [Abstract][Full Text] [Related]
11. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age.
Gai L; Zhang J; Zhang H; Gai P; Zhou L; Liu Y
Contraception; 2011 Mar; 83(3):218-22. PubMed ID: 21310282
[TBL] [Abstract][Full Text] [Related]
12. [Status of bone mineral density after the long-standing application of contraception Depo-Provera].
Zeman S; Havlík P; Zemanová J; Němec D
Ceska Gynekol; 2013 Jan; 78(1):116-24. PubMed ID: 23607391
[TBL] [Abstract][Full Text] [Related]
13. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
Cundy T; Ames R; Horne A; Clearwater J; Roberts H; Gamble G; Reid IR
J Clin Endocrinol Metab; 2003 Jan; 88(1):78-81. PubMed ID: 12519833
[TBL] [Abstract][Full Text] [Related]
15. Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study.
Tang OS; Tang G; Yip PS; Li B
Contraception; 2000 Oct; 62(4):161-4. PubMed ID: 11137068
[TBL] [Abstract][Full Text] [Related]
16. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women.
Zhang MH; Zhang W; Zhang AD; Yang Y; Gai L
Chin Med J (Engl); 2013 Nov; 126(21):4043-7. PubMed ID: 24229671
[TBL] [Abstract][Full Text] [Related]
17. Changes in calcium metabolism and bone mineral density in new users of medroxyprogesterone acetate during the first year of use.
Quintino-Moro A; Zantut-Wittmann DE; Silva Dos Santos PN; Silva CA; Bahamondes L; Fernandes A
Int J Gynaecol Obstet; 2019 Dec; 147(3):319-325. PubMed ID: 31479152
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Sep; 56(3):153-5. PubMed ID: 9347205
[TBL] [Abstract][Full Text] [Related]
19. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.
Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM
Contraception; 2004 Feb; 69(2):99-104. PubMed ID: 14759613
[TBL] [Abstract][Full Text] [Related]
20. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
Rahim A; Holmes SJ; Adams JE; Shalet SM
Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
